Authors/Disclosures
|
Gregory Krauss, MD
(Johns Hopkins University)
|
Dr. Krauss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle. Dr. Krauss has received stock or an ownership interest from EpiWatch. |
|
Elinor Ben-Menachem, MD, FAAN
(Dept of Clinical Neuroscience)
|
Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic. |
|
Sarah J. Banks, PhD
(Cleveland Clinic Lou Ruvo Center for Brain Health)
|
No disclosure on file |
|
Ruta Mameniskiene, MD
(Vilnius University Hospital)
|
Dr. Mameniskiene has nothing to disclose. |
|
|
No disclosure on file |
|
Sreya Radhakrishna, MD
(Boston Children's Health Physicians Pediatric Neurology)
|
Dr. Radhakrishna has nothing to disclose. |
|
John G. Whitesides
|
John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB. |
|
Melissa Brock
(SCHWARZ BIOSCIENCES, Inc.)
|
Melissa Brock has nothing to disclose. |